Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
|
|
GeneDx Holdings Corp.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2023 |
4
| Saad Kareem (Chief Transformation Officer) has filed a Form 4 on GeneDx Holdings Corp.|
Txns:
| Sold 85 shares
@ $3.5607, valued at
$302.7
Exercised 273 restricted stock units
@ $0 |
|
| 08/18/2023 |
4
| PFENNIGER RICHARD C JR (Director) has filed a Form 4 on GeneDx Holdings Corp.|
Txns:
| Bought 5,000 shares
@ $5.1046, valued at
$25.5k
|
|
| 08/08/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/08/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 08/08/2023 |
8-K
| Investor presentation, Quarterly results |
| 07/27/2023 |
4
| White Karen Ann (Chief People Officer) has filed a Form 4 on GeneDx Holdings Corp.|
Txns:
| Sold 61 shares
@ $7.41, valued at
$452
Exercised 137 restricted stock units
@ $0 |
|
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/24/2023 |
8-K
| Quarterly results |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2023 |
4
| White Karen Ann (Chief People Officer) has filed a Form 4 on GeneDx Holdings Corp.|
Txns:
| Sold 45 shares
@ $5.99, valued at
$269.6
Exercised 99 restricted stock units
@ $0 |
|
| 07/05/2023 |
4
| Saad Kareem (Chief Transformation Officer) has filed a Form 4 on GeneDx Holdings Corp.|
Txns:
| Sold 83 shares
@ $5.99, valued at
$497.2
Exercised 273 restricted stock units
@ $0 |
|
| 06/09/2023 |
SC 13G/A
| Flynn James E reports a 4.9% stake in GeneDX Holdings Corp. |
| 06/06/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 05/31/2023 |
4
| Ro Isaac (Former CFO) has filed a Form 4 on GeneDx Holdings Corp.|
Txns:
| Sold 2,296 shares
@ $1.3187, valued at
$3k
Exercised 7,396 restricted stock units
@ $0 |
|
| 05/31/2023 |
4
| Assad Shawn (Former CAO) has filed a Form 4 on GeneDx Holdings Corp.|
Txns:
| Sold 1,497 shares
@ $1.3187, valued at
$2k
Sold 3,166 shares
@ $2.17, valued at
$6.9k
Exercised 5,139 restricted stock units
@ $0
Exercised 10,457 restricted stock units
@ $0 |
|
| 05/18/2023 |
4
| Feeley Kevin (CFO) has filed a Form 4 on GeneDx Holdings Corp.|
Txns:
| Sold 1,516 shares
@ $6.4985, valued at
$9.9k
|
|
| 05/18/2023 |
4
| Stueland Katherine (CEO) has filed a Form 4 on GeneDx Holdings Corp.|
Txns:
| Sold 8,685 shares
@ $6.4985, valued at
$56.4k
|
|
| 05/09/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/09/2023 |
8-K
| Investor presentation, Quarterly results |
| 05/08/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 05/04/2023 |
4
| Clark Daniel Emmett (Former Secretary and GC) has filed a Form 4 on GeneDx Holdings Corp.|
Txns:
| Sold 1,207 shares
@ $1.3187, valued at
$1.6k
Exercised 4,005 restricted stock units
@ $0 |
|
| 05/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/02/2023 |
4
| Stueland Katherine (CEO) has filed a Form 4 on GeneDx Holdings Corp.|
Txns:
| Exercised 511,364 restricted stock units
@ $0 |
|
| 05/02/2023 |
4
| Feeley Kevin (CFO) has filed a Form 4 on GeneDx Holdings Corp.|
Txns:
| Exercised 99,432 restricted stock units
@ $0 |
|
| 04/28/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/28/2023 |
4
| Saad Kareem (Chief Transformation Officer) has filed a Form 4 on GeneDx Holdings Corp.|
Txns:
| Sold 2,612 shares
@ $1.3187, valued at
$3.4k
Exercised 9,005 restricted stock units
@ $0 |
|
|
|
|